USP2: Ubiquitin Specific Peptidase 2

A deubiquitinating enzyme involved in cell cycle regulation, apoptosis, and cancer.

Gene Information Card

Symbol USP2
Full Name Ubiquitin Specific Peptidase 2
Gene Type protein-coding
Chromosomal Location 11q23.3
NCBI Gene ID 9099 ncbi.nlm.nih.gov/gene/9099
Ensembl ID ENSG00000148840
UniProt ID O75604
OMIM ID 604725
HGNC ID 12618
Aliases UBP41, USP2-AS1

Description

USP2 (Ubiquitin Specific Peptidase 2) encodes a deubiquitinating enzyme that removes ubiquitin from target proteins, thereby regulating protein stability, cell cycle progression, and apoptosis. It is involved in the deubiquitination of MDM2, FAS, and other substrates, and has been implicated in various cancers and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Prostate Cancer USP2 overexpression stabilizes MDM2, leading to p53 degradation and tumor progression. PMID: 16959974
Breast Cancer USP2 deubiquitinates and stabilizes FAS, promoting cell survival. PMID: 21502526
Colorectal Cancer USP2 upregulation correlates with poor prognosis and increased proliferation. PMID: 23431179
Obesity USP2 regulates insulin signaling and adipogenesis via deubiquitination of IRS-1. PMID: 23563491

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Prostate 8.3 Medium
Breast 5.1 Low
Colon 4.7 Low
Liver 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.2 High expression
HeLa 7.8 Medium expression
MCF7 6.4 Medium expression
LNCaP 9.1 High expression
HCT116 5.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.112G>A (p.Gly38Arg) Missense <0.01% Unknown
c.457C>T (p.Arg153Trp) Missense <0.01% Unknown
c.763_764insA Frameshift <0.01% Loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., c.763_764insA) are predicted to cause loss of deubiquitinase activity.

Gain of Function (GOF)

Not well characterized; overexpression in cancer suggests potential gain-of-function via substrate stabilization.

Dominant Negative (DN)

No dominant negative mutations reported.

Gene Ontology (GO)

• cysteine-type deubiquitinase activity • ubiquitin-specific protease activity
• protein deubiquitination • proteasome-mediated ubiquitin-dependent protein catabolic process
• cell cycle • apoptotic process

Pathways

• p53 signaling pathway
• Ubiquitin mediated proteolysis
• Apoptosis

Protein Summary

USP2 is a 605-amino acid deubiquitinating enzyme containing a catalytic cysteine box and a ubiquitin-interacting motif. It cleaves ubiquitin from specific substrates, including MDM2, FAS, and IRS-1, thereby regulating protein stability and signaling. The protein is predominantly cytoplasmic and is highly expressed in testis and prostate.

Related Products

Product name Cat.No. Species Gene ID
USP2 Knockout HEK293 Cell Line EDJ-KQ1072 Human 9099 Details Get a Quote
USP26 Knockout HEK293 Cell Line EDJ-KQ2375 Human 83844 Details Get a Quote
USP20 Knockout HEK293 Cell Line EDJ-KQ2461 Human 10868 Details Get a Quote
USP21 Knockout HEK293 Cell Line EDJ-KQ2970 Human 27005 Details Get a Quote
USP24 Knockout HEK293 Cell Line EDJ-KQ7987 Human 23358 Details Get a Quote
USP28 Knockout HEK293 Cell Line EDJ-KQ12007 Human 57646 Details Get a Quote
USP22 Knockout HEK293 Cell Line EDJ-KQ16074 Human 23326 Details Get a Quote
USP25 Knockout HEK293 Cell Line EDJ-KQ16075 Human 29761 Details Get a Quote
USP27X Knockout HEK293 Cell Line EDJ-KQ16076 Human 389856 Details Get a Quote
USP29 Knockout HEK293 Cell Line EDJ-KQ16077 Human 57663 Details Get a Quote
USP28 Knockout HCT 116 Cell Line EDJ-KQ17922 Human 57646 Details Get a Quote
USP25 Knockout HCT 116 Cell Line EDJ-KQ18080 Human 29761 Details Get a Quote
USP2 Knockout A-549 Cell Line EDJ-KQ20206 Human 9099 Details Get a Quote
USP2 Knockout HCT 116 Cell Line EDJ-KQ20207 Human 9099 Details Get a Quote
USP20 Knockout A-549 Cell Line EDJ-KQ23007 Human 10868 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: